This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...

CDI has already met with some early success in the use of iPSC-derived cardiomyocytes for the characterization of drug effects. “Adult heart cells coming out of a cadaver don't beat,” says ...

EHM allografts restore heart muscle safely, offering a breakthrough in heart failure treatment with no arrhythmia risk.

In several pre-clinical studies, iPSC-derived cardiomyocytes have been shown to improve heart function. The LAPiS study is a 52-week, phase 1/2, open-label, dose-escalation study conducted at ...

His team chose a commercial organ chip that contained two separate fluid channels. 4 In one channel, they grew iPSC-derived cardiomyocytes to mimic heart muscle tissue, and in the other channel, they ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Ncardia, a leading human induced pluripotent stem cell (hiPSC) technology company, today announced the launch of Ncyte® Heart ...

today announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation. Using this assay, ...

The industry-trusted 2nd iPSC-Derived Cell Therapies Summit provides a dedicated forum to voice challenges, collaborate and spark conversations with the community committed to advancing iPSC ...

Use Applied StemCell's (ASC) new GMP facility, comprised of five cleanrooms equipped with cutting-edge technology, to develop the next generation of iPSC-derived therapeutics. We have dedicated ...